Novabay Pharmaceuticals (NBY)
NYSE MKT:NBY

NovaBay Pharma (NBY) Cash flow

612 Followers

NovaBay Pharma Cash Flow

NBY's free cash flow for Q4 2023 was $-316.00K. For the 2023 fiscal year, NBY's free cash flow was decreased by $2.62M and operating cash flow was $-314.00K. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ -4.13M$ -4.13M$ -6.65M$ -10.35M$ -4.72M$ -7.93M
Investing Cash Flow
$ -19.00K$ -19.00K$ -112.00K$ -12.04M$ -26.00K$ -19.00K
Financing Cash Flow
$ 1.91M$ 1.91M$ 4.63M$ 16.79M$ 9.76M$ 11.70M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 16.77M$ 3.61M$ 5.85M$ 6.83M$ 12.43M$ 7.41M
Income Tax Paid Supplemental Data
$ 359.00K$ 359.00K$ 24.00$ 21.00$ 14.00K$ 14.00K
Interest Paid Supplemental Data
$ 326.00K$ 326.00K$ 17.00K-$ 49.00K$ 148.00K
Issuance Of Capital Stock
---$ 1.78M$ 5.22M$ 9.30M
Issuance Of Debt
$ -1.66M$ -1.66M$ -105.00K$ 105.00K$ 0.00$ 3.00M
Repayment Of Debt
$ -1.66M$ -1.66M-$ 105.00K$ -2.56M$ -652.00K
Free Cash Flow
$ -4.15M$ -4.15M$ -6.77M$ -10.40M$ -4.75M$ -7.95M
Domestic Sales
------
Foreign Sales
------
Currency in USD

NovaBay Pharma Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis